An economic evaluation of early versus late referral of patients with progressive renal insufficiency

American Journal of Kidney Diseases

Volumn 38, Issue 5, 2001, Pages 1122-1128

  McLaughlin, Kevin ^a   Manns, Braden ^a   Culleton, Bruce ^a   Donaldson, Cam ^a   Taub, Kenneth ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Economic evaluation; End stage renal disease (ESRD); Progressive renal insufficiency (PRI); Referral

Indexed keywords

ARTICLE; CANADA; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PATIENT REFERRAL; SURVIVAL; UNITED STATES;

EID: 0034748227     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.28619     Document Type: Article

References (30)

1. Late referral of end-stage renal failure
2. Early deaths on renal replacement therapy: The need for early nephrological referral
3. Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center
4. Detrimental effects of late referral in patients with chronic renal failure: A case-control study
5. Can we improve early mortality in patients receiving renal replacement therapy?
6. Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: A meta-analysis of randomized trials
7. An intervention for employment maintenance among blue-collar workers with end-stage renal disease
8. Live and learn: Patient education delays the need to initiate renal replacement therapy in end-stage renal disease
9. Multidisciplinary predialysis programs: Quantification and limitations of their impact on patient outcomes in two Canadian settings
10. Early referral and its impact on emergent first dialyses, health care costs, and outcome
11. Progression of chronic renal failure
12. Factors affecting rate of progressive renal decline: Observations in a non-clinical trial setting
13. Clinical practice guidelines for initiation of dialysis
14. Comparative mortality of hemodialysis and peritoneal dialysis in Canada
15. A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis
16. Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada
17. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant
18. Improved graft survival after renal transplantation in the United States, 1988 to 1996
19. Hospital utilization among chronic dialysis patients
20. Cost analysis of dialysis treatments for end-stage renal disease (ESRD)
21. A study of the quality of life and cost-utility of renal transplantation
22. Guidelines for authors and peer reviewers of economic submissions to the BMJ
23. To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy
24. End-stage renal disease in Canada: Prevalence projections to 2005
25. Elevated levels of serum creatinine: Recommendations for management and referral
26. Morbidity and mortality of renal dialysis: An NIH consensus conference statement
27. Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey